Literature DB >> 31541281

The same mutation in a family with adenosine deaminase 2 deficiency.

Betul Sozeri1, Gozde Ercan2, Ozlem Akgun Dogan3, Jale Yıldız4, Ferhat Demir2, Levent Doğanay4.   

Abstract

The deficiency of adenosine deaminase 2 (DADA2) has recently been defined as a monogenetic autosomal recessive autoinflammatory disease. DADA2 is mainly characterized by high fever, livedo racemose, early-onset stroke, mild immunodeficiency and clinically polyarteritis nodosa (PAN)-like symptoms. Mutations in CECR1 (cat eye syndrome chromosome region, candidate 1) are responsible for DADA2. Livedoid racemose, lacunar infarct due to involvement in small vessel of the central nervous system, peripheral neuropathy, digital ulcers and loss of fingers are predominantly seen in the disease which could progress to end-stage organ failure and death in some patients. A wide spectrum of severity in phenotype as well as in the age of onset has been reported in the literature. This phenotypic variability is also found in our clinical practice even in patients with the same mutation. Here, we present a family diagnosed with DADA2, with the previously reported p.Gly47Arg mutation in CECR1.

Entities:  

Keywords:  Adenosine deaminase 2 deficiency; Polyarteritis nodosa and CECR1

Year:  2019        PMID: 31541281     DOI: 10.1007/s00296-019-04444-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  3 in total

1.  Mutant ADA2 in vasculopathies.

Authors:  Lien Van Eyck; Adrian Liston; Carine Wouters
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

2.  Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis.

Authors:  R A Sari; S Taysi; O Yilmaz; N Bakan
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

3.  Testing the Model for Predicting Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.

Authors:  Seza Ozen; Selcan Demir; Ezgi Deniz Batu
Journal:  J Rheumatol       Date:  2019-06-15       Impact factor: 4.666

  3 in total
  4 in total

Review 1.  Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.

Authors:  Benzeeta Pinto; Prateek Deo; Susmita Sharma; Arshi Syal; Aman Sharma
Journal:  Clin Rheumatol       Date:  2021-03-31       Impact factor: 2.980

Review 2.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

3.  The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid.

Authors:  Barbara Kutryb-Zajac; Ada Kawecka; Fionä Caratis; Krzysztof Urbanowicz; Alicja Braczko; Tomomi Furihata; Bartosz Karaszewski; Ryszard T Smolenski; Aleksandra Rutkowska
Journal:  Front Mol Neurosci       Date:  2022-09-20       Impact factor: 6.261

Review 4.  The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.

Authors:  Jennifer Lee Kendall; Jason Michael Springer
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.